tert-Butyl (5-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentyl)carbamate

Catalog No. :
ACESHV902
CAS No. :
192212-24-1
Molecular Formula :
C14H22N2O4
Molecular Weight :
282.34

IUPAC Name:tert-butyl (5-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentyl)carbamate

tert-Butyl (5-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$248.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (5-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentyl)carbamate
IUPAC Nametert-butyl (5-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentyl)carbamate
MDL No.MFCD22682785
Molecular FormulaC14H22N2O4
Molecular Weight282.34
SMILESO=C(NCCCCCN1C(C=CC1=O)=O)OC(C)(C)C
InChI KeyOSGXOKMWPDUSTI-UHFFFAOYSA-N
SynonymCarbaMic acid, [5-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)pentyl]-, 1,1-diMethylethyl ester;N-(5-(tert-tutoxylear tonyl)aminopentyl)maleimide;1-(5-N-Boc-aminopentyl)-1H-pyrrole-2,5-dione;tert-butyl(5-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentyl)carbamate;Carbamic acid, N-[5-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)pentyl]-, 1,1-dimethylethyl ester;1-[5-(Boc-amino)pentyl]-1H-pyrrole-2,5-dione
CAS No.192212-24-1

Synthetic Route by SureRoute

1. ACESHV902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. ACKUPS734 route compound structure diagram
    ACKUPS73455750-53-3 In Stock
  4. Then
  5. ACESHV902 route product structure diagram
    ACESHV902192212-24-1
Inquiry

2. ACESHV902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACESHV902 route product structure diagram
    ACESHV902192212-24-1
Inquiry

Comments (0)